Literature DB >> 50250

Intramural injection of ethanol under direct vision for the treatment of protuberant lesions of the stomach.

T Otani, T Tatsuka, K Kanamaru, S Okuda.   

Abstract

The experimental production of gastric ulcers in dogs by subnucosal injection of ulcerogeic agents is described. The most satisfactory agent tested was 95% ethanol, because it produced immediate changes in the mucosa which delineated the size of the ulcer. The depth of ulceration could be controlled and the ulcer healed readily. Using this technique of ulcer formation, treatment of protuberant gastric lesions was attempted. Eradication of the pedunculated and narrow-based polyps in stomach was almost totally successful by injection into the base. Wide-based lesions, including atypical hyperplasia and the elevated type of early gastric cancer, were also completely eradicated in 96% of the treated cases. There have been no complications. An initial assessment of the practicality of this method in poor risk patients is presented.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 50250

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  3 in total

1.  Dopaminergic control of gastric mucosal blood flow in humans. A study with endoscopic laser Doppler flowmetry coupled with gastric submucosal drug injection.

Authors:  M Kaise; H Echizen; T Ishizaki
Journal:  Dig Dis Sci       Date:  1993-07       Impact factor: 3.199

2.  Endoscopic submucosal dissection for gastric cancer.

Authors:  Mitsuhiro Fujishiro
Journal:  Curr Treat Options Gastroenterol       Date:  2008-04

3.  Bronchoscopic ethanolamine injection therapy in patients with persistent air leak from chest tube drainage.

Authors:  Ah Leum Lim; Cheol-Hong Kim; Yong Il Hwang; Chang Youl Lee; Jeong-Hee Choi; Taerim Shin; Yong-Bum Park; Seung-Hun Jang; Sang Myeon Park; Dong-Gyu Kim; Myung Goo Lee; In-Gyu Hyun; Ki-Suck Jung; Ho-Seung Shin
Journal:  Tuberc Respir Dis (Seoul)       Date:  2012-05-29
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.